12 hrs ago
Mylan Announces Acquisition of Rights to Novel LAMA Respiratory Compound from Pfizer
Mylan Inc. today announced that it has received all regulatory approvals and has completed an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize a novel long-acting muscarinic antagonist compound for various indications.
Tue Dec 17, 2013
Tuesday 12/17 Insider Buying Report: MYL, PRXL
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.
Mylan Announces Settlement Agreement for First-to-File Generic Version of TARGRETINA
Bexarotene is the generic version of TARGRETINA , which is indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
Sun Dec 15, 2013
The Papillion Times
Incoming CEO already has shaken up GM's culture
Product development, notably the introduction of the 2014 Chevrolet Corvette Stingray, and recruiting top talent to General Motors have been two of Mary Barra's top priorities in recent years.
Fri Dec 13, 2013
Insider Selling: Daniel Rizzo Jr Sells 70,683 Shares of Mylan Stock
Mylan CAO Daniel Rizzo, Jr. sold 70,683 shares of Mylan stock in a transaction dated Thursday, December 12th.
Mon Dec 09, 2013
Progaming Platforms Corp Files (8-K) Disclosing Change in Directors or Principal Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Fri Dec 06, 2013
Mylan markets Cabergoline Tablets
The Southpointe-based Mylan said it received final approval from the Food and Drug Administration for the Cabergoline Tablets USP, which had about $41.67 million in sales in the 12 months ended Sept.
Thu Dec 05, 2013
How To Make Money In Any Market And 5 Stocks To Buy Right Now
Tom Forester: We are a large cap value fund using a low price/earnings ratio and a bottom-up stock picking approach.
Strides Arcolab completes $1.75 bn sale of Agila Specialties to Mylan Laboratories Inc.
Drug maker Strides Arcolab Ltd today said it has completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to USD 1.75 billion.
Wed Dec 04, 2013
Mylan May Hold Back $250 Million in Indian Drugmaker Deal
Strides Arcolab Ltd. won't get $250 million of the $1.75 billion anticipated from the sale of its injectable drugs unit to Mylan Inc. unless regulatory concerns at one of the Indian drugmaker's factories are resolved.
Mylan Completes Acquisition of Agila to Create Leading Global Injectables Platform
Since the initial announcement of this acquisition, the final transaction terms have been restructured to include provisions such as a hold back, or contingent consideration, of total purchase price, which will be payable in whole or in part to Strides upon satisfaction of certain regulatory conditions, and an enhanced escrow arrangement to fund ... (more)
Mon Dec 02, 2013
Mylan, Elton John foundation give $1M to fight HIV
Mylan Inc. and the Elton John AIDS Foundation announced Sunday they would give a total of $1 million to an organization fighting to end mother-to-child transmission of HIV in Nigeria.
Mylan, Elton John foundation give $1M to fight HIV
The Elton John AIDS Foundation and Mylan Inc. will make a combined $1 million donation to help eliminate mother-to-child transmission of HIV in Nigeria.
Sat Nov 30, 2013
Hot Stocks: Canadian Natural Resource Ltd (USA)(NYSE:CNQ),...
Jet Life Penny Stocks provides investors with the some of the most Awesome Penny Stock alerts on a regular basis.
Wed Nov 27, 2013
Mylan-Biocon prepare to launch biosimilar cancer drug
Canonsburg generic drug maker Mylan Inc. plans to market a biosimilar medication in India early next year, the first product developed in partnership with Indian biotech giant Biocon.
Tue Nov 26, 2013
NASDAQ Gainers Watch List: Adobe Systems Inc. (NASDAQ:ADBE) and...
Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Adobe Systems Inc. and Mylan, Inc. .
Mon Nov 25, 2013
Mylan-Biocon Receive First Indian Biosimilar Regulatory Approval for Herceptin
Mylan Inc. has announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India.
Teva, Mylan settle MS drug patent dispute
Affiliates of Teva Pharmaceutical Industries and Mylan Inc. have agreed to settle and dismiss pending patent litigation involving Copaxone in the United Kingdom, the Netherlands and France.
Wed Nov 20, 2013
Mylan, Inc. (NASDAQ:MYL) and Expedia Inc. (NASDAQ:EXPE) Added to...
Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Mylan, Inc. and Expedia Inc. .
Tue Nov 19, 2013
Mylan Announces Pricing of $2.0 Billion of Senior Notes
PITTSBURGH, Nov. 19, 2013 /PRNewswire/ -- Mylan Inc. today announced the pricing of a registered offering of aggregate principal amount of $2.0 billion in bond issuance comprised of: -- $500 million aggregate principal amount of 1.35% Senior Notes due 2016; -- $500 million aggregate principal amount of 2.55% Senior Notes due 2019; -- $500 million ... (more)